APYX Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 72.46
EPS (TTM)$-0.220.0% YoY
Profit margin-16.4%HEALTHCARE
Market cap$172.1MMicro cap
Wall Street coverage
$6.50median target· current $1.33 (+388.7%)5 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 72.46
- PEG ratio
- 0.59
- P/B
- 13.74
- P/S (TTM)
- 3.15
- EV/EBITDA
- -5.33
Profitability & growth
- ROE (TTM)
- -76.5%
- Operating margin
- -7.3%
- Revenue growth YoY
- 32.5%
- Dividend yield
- —
- Beta
- 1.39
Last earnings
May 7, 2026 · Estimate $-0.11 · Reported $-0.05
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Apyx Medical Inc
Company profileApyx Medical Corporation, an energy technology company, develops, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. The company is headquartered in Clearwater, Florida.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 5115 ULMERTON ROAD, CLEARWATER, FL
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$172.1M
Shares outstanding$41.9M
52W high$5.08
52W low$1.59
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent